Figure No.
|
Figure Title
|
Figure 1-1
|
China’s GDP and year-on-year growth rate, 2004-2013
|
Figure 1-2
|
China’s foreign trade, 2004-2013
|
Figure 1-3
|
Total investment in fixed assets in China, 2004-2013
|
Figure 1-4
|
Investment in fixed assets under construction and newly built (farmers excluded) in China, 2004-2012
|
Figure 1-5
|
Foreign capital actually utilized in China, 2004-2013
|
Figure 1-6
|
China’s outward foreign direct investment (financing excluded), 2008-2013
|
Figure 1-7
|
China’s population, 2004-2013
|
Figure 1-8
|
China’s demographic composition, 2004-2013
|
Figure 1-9
|
Per capita income of residents in China, 2004-2013
|
Figure 1-10
|
Total health expenditure in China, 2004-2013
|
Figure 1-11
|
Per capita health expenditure in China, 2004-2012
|
Figure 2-1
|
Morbidity and mortality of infectious diseases in China, 2004-2013
|
Figure 2-2
|
Top 10 countries/regions of diabetes in the world in terms of number of diabetic, 2013
|
Figure 3-1
|
Gross industrial output of pharmaceutical industry in China, 2006-2013
|
Figure 3-2
|
Global pharmaceuticals sales and its growth rate, 2004-2013
|
Figure 3-3
|
Structure of gross industrial output of pharmaceutical industry in China, 2013
|
Figure 3-4
|
Sales revenue of pharmaceutical industry in China, 2006-2013
|
Figure 3-5
|
Profit and profit margin of pharmaceutical industry in China, 2006-2013
|
Figure 3-6
|
Performance of China’s pharmaceutical circulation, 2006-2013
|
Figure 3-7
|
Terminal medicine market size in China, 2007-2013
|
Figure 3-8
|
Sub-market structure of pharmaceutical industry in China in terms of value (at retail level), 2007-2013
|
Figure 3-9
|
Terminal medical treatment market size in China, 2007-2013
|
Figure 3-10
|
Market share of key categories in China’s chemical pharmaceuticals in terms of value (hospital terminate), 2007-2013
|
Figure 3-11
|
Market share of key categories in China’s TCM preparations in terms of value (hospital terminate), 2007-2013
|
Figure 3.1-1
|
Total revenue of top 100 companies and their share in gross sales of China's pharmaceutical industry, 2009-2013
|
Figure 3.1-2
|
Scale distribution of top 100 companies in China’s pharmaceutical industry in terms of revenue, 2012-2013
|
Figure 3.3-1
|
Gross sales of China’s pharmaceutical circulation industry, 2008-2013
|
Figure 3.3-2
|
Structure (sub-market level) of pharmaceutical market in China in terms of sales value, 2013
|
Figure 3.3-3
|
Structure of pharmaceutical market in China in terms of sales value at retail pharmacy level, 2013
|
Figure 3.3-4
|
Geographical distribution of pharmaceuticals sales in China in terms of sales value, 2013
|
Figure 3.3-5
|
Ownership structure of enterprises in China in terms of revenue, 2013
|
Figure 3.3-6
|
Distribution structure of pharmaceuticals in terms of value of distributed pharmaceuticals, 2013
|
Figure 3.3-7
|
Medicine circulation of direct-reporting enterprises in China, 2012-2013
|
Figure 3.3-8
|
Share of revenue of different scale medicine wholesale enterprises in the total of pharmaceutical market in China, 2011-2013
|
Figure 3.3-9
|
Number of key medicine wholesale enterprises in China in terms of revenue, 2011-2013
|
Figure 3.4-1
|
Pharmaceutical R&D expenditures by the public sector and private industry in China, 2007-2012
|
Figure 3.4-2
|
Compound annual growth rate (2006-2012) of pharmaceutical R&D expenditures of some countries/regions
|
Figure 4.2-1
|
Supply chain of pharmaceuticals in China
|
Figure 4.2-2
|
Number of participants in the supply chain of medicine in China, 2013
|
Figure 4.2-3
|
Number of wholesale enterprises and retail chain enterprises of medicine in China, 2009-2012
|
Figure 4.2-4
|
Number of retail pharmacies in China, 2008-2012
|
Figure 4.2-5
|
Market share of retail terminal and other terminals in China, 2007-2013
|
Figure 4.2-6
|
Number of provincial pharmacy leagues in China, 2009-2013
|
Figure 4.2-7
|
Gross sales of provincial pharmacy leagues in China, 2010-2013
|
Figure 4.2-8
|
Medicine enterprises (with license) and market size of E-commerce of medicine in China, 2010-2013
|
Figure 4.3-1
|
Number of listed companies in pharmaceutical industry in China by sub-market, 2013
|